S Chou, K Song, J Wu, T Bo… - The Journal of Infectious …, 2022 - ncbi.nlm.nih.gov
Background In separate phase 2 trials, 120 patients received maribavir for cytomegalovirus
(CMV) infection failing conventional therapy (trial 202) and 119 received maribavir for …